Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

7 Jan 2008 07:00

Tarsus Group PLC07 January 2008 7 January 2008 TARSUS GROUP PLC TRADING UPDATE Tarsus Group plc ('Tarsus' or 'the Group'), the international media group withinterests in exhibitions, conferences, publishing and online media hascontinued to trade well in the second half of 2007 with strong performances fromall of its key products. Group like-for-like organic revenue growth for theyear to 31 December 2007 has been 15% and, as a result, the Board expects fullyear 2007 results to be towards the top end of market expectations. Labelexpo Europe, the Group's second largest exhibition, produced revenue growth10% above that of the 2005 event and rebookings for 2009 are already at 90% ofthe total 2007 event. The three important French exhibitions Heavent (event marketing), IP Convergence (IT) and Educatec (education) were all well ahead of2006 and contributed to strong like-for-like organic revenue growth from theFrench division of 14% for the year as a whole. The final medical event of theyear, Anti-Ageing Las Vegas, was a great success with revenues and attendees up35% and 30% respectively over 2006. The development of our emerging markets portfolio was significantly acceleratedwith the November 2007 acquisition of Fairs & Exhibitions Limited, whose keyevent is the Dubai Air Show. This biennial show, which is now the Group's largest, was extremely well received with visitor numbers up nearly 30% from the2005 event to 45,000 and record customer orders in excess of US$100 billion.The event will move to a new purpose-built venue in 2009 which has resulted inrequests for large upgrades in space from major exhibitors. Other emerging market events were China-focused in the second half and our keyevent, the third edition of Labelexpo Asia in Shanghai, saw revenues rise by12% above the 2005 event and visitor numbers by 54%. Rebookings are strong and well ahead of the previous cycle. Caroo, our online business, has continued its strong momentum with like-for-likeorganic revenues up by 21% for the full year. We have appointed a newdivisional CEO in the US to drive growth in that market following theacquisition of the DMS Group in July. Outlook for 2008 The broadening of the Group's base is an important step in underpinning ourability to grow consistently in the years ahead. During 2007 we have continuedto expand the number of sectors served by the Group and made good progress in diversifying our revenues geographically. Average emerging market revenues forthe 2007/2008 cycle are expected to be approximately 16% of the total up from5% for the 2005/2006 cycle. The Group is strongly second half weighted and, with the major Labelexpo showreturning to the US from Europe in 2008, dollar exposure will be higher than in2007. Our significant events in the first quarter of 2008 - the US Off-Price show, the Mod'Amont clothing accessories event in Paris and GESS (a neweducational show in Dubai) - are developing extremely well. Overall, forwardbookings are strong and the Board remains confident that 2008 will be anotheryear of strong like-for-like growth for the Group. The Group expects to announce its preliminary results for the year to 31December 2007 on 3 March 2008. Ends For further information please contact: Tarsus Group plc: Douglas Emslie: Group Managing Director: Tel 020 8846 2700 Media: Matthew Moth :Madano Partnership: Tel: 020 7593 4000 Investors: Neville Harris : IRFocus: Tel: 020 7593 4215 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Nov 20087:00 amRNSInterim Management Statement
31st Oct 200812:35 pmRNSResults of Court Meeting and General Meeting
16th Oct 20084:15 pmRNSHolding(s) in Company
8th Oct 20083:38 pmRNSIntroduction of a new UK-listed holding company
26th Sep 20087:00 amRNSAdditional Listing
19th Aug 20082:39 pmRNSHolding(s) in Company
15th Aug 20081:54 pmRNSDirector/PDMR Shareholding
11th Aug 20083:37 pmRNSDirector/PDMR Shareholding
1st Aug 200810:01 amRNSTotal Voting Rights - Replace
31st Jul 20086:22 pmRNSInterim Results - Replacement
31st Jul 20087:00 amRNSInterim Results
31st Jul 20087:00 amRNSTotal Voting Rights
24th Jul 20082:00 pmRNSNotice of Results
16th Jul 20082:57 pmRNSPDMR Shareholding & Additiona
7th Jul 200811:06 amRNSHolding(s) in Company
2nd Jul 200810:43 amRNSHolding(s) in Company
30th Jun 200810:45 amRNSPDMR Shareholding & Additiona
30th Jun 20087:00 amRNSDirectorate Change
30th Jun 20087:00 amRNSTrading Statement
27th Jun 20083:30 pmRNSHolding(s) in Company
24th Jun 20086:26 pmRNSDirector/PDMR Shareholding
2nd Jun 200811:26 amRNSPDMR Shareholding & Additiona
30th May 200810:28 amRNSTotal Voting Rights
16th May 200812:11 pmRNSHolding(s) in Company
16th May 20087:00 amRNSDirector/PDMR Shareholding
24th Apr 20084:06 pmRNSHolding(s) in Company
23rd Apr 20089:41 amRNSAdditional Listing
17th Apr 20083:14 pmRNSAGM Statement
17th Apr 20087:00 amRNSInterim Management Statement
7th Apr 20084:29 pmRNSDirector/PDMR Shareholding
4th Apr 20084:50 pmRNSDirector/PDMR Shareholding
4th Apr 20084:48 pmRNSHolding(s) in Company
1st Apr 20085:33 pmRNSHolding(s) in Company
1st Apr 20084:45 pmRNSHolding(s) in Company
20th Mar 200812:02 pmRNSAnnual Report and Accounts
3rd Mar 20087:00 amRNSAcquisition
3rd Mar 20087:00 amRNSFinal Results
31st Jan 20085:15 pmRNSTotal Voting Rights
31st Jan 20085:12 pmRNSHolding(s) in Company
31st Jan 20085:12 pmRNSHolding(s) in Company
17th Jan 20085:21 pmRNSAdditional Listing
7th Jan 20087:00 amRNSTrading Statement
20th Nov 200710:56 amRNSAdditional Listing
12th Nov 20077:00 amRNSJoint Venture
12th Nov 20077:00 amRNSAcquisition
2nd Nov 200711:56 amRNSAdditional Listing
1st Nov 20073:37 pmRNSTotal Voting Rights
26th Oct 20071:55 pmRNSHolding(s) in Company
23rd Oct 200711:52 amRNSAdditional Listing
23rd Oct 200711:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.